The GRP75‐deficient mice showed lower tumor volume and tumor weight (42.9% and 28.4% lower, respectively) than the controls, and the effects of JX57 on the knockdown tumor were not significantly different from those in the vehicle group (Figure 4I). The gene discussed is HSPA9; the disease is neoplasm.